It has been widely accepted that intramuscular administration of synthetic 11-desoxycorticosterone acetate (DOCA) causes urinary retention of sodium, chloride and water, and loss of potassium both in normal subjects and in those with adrenocortical insufficiency."'8"' There is, however, a paucity of published information concerning many aspects of this question which have an important bearing on the problem of the adrenocortical regulation of fluid, electrolyte, and nitrogen balance. In an effort to elucidate this problem, detailed balance studies have been conducted on normal young adults who were given 20 to 40 mgm. of DOCA intramuscularly for periods of three to eleven days.
other subjects who were not receiving intravenous fluid was fixed at 2000 to 3000 cc. per day.
Intake in each case was calculated from the average of two or three analyses of duplicate diets and from the analysis of the saline solutions, when these were used. Output was determined by the analysis of 24-hour urine collections preserved with thymol and chloroform and from the analysis of stools pooled in three-to seven-day periods.
Urine and nitric acid digests of homogenized stools and diets were analyzed for sodium and potassium using an internal standard flame photometer. Determinations of chloride,S' nitrogen,' phosphorus,' titratable acid,"3 ammonia,' and pH (glass electrode) were made on every urine specimen. All urines were acid and no attempt was made to prevent loss of carbon dioxide from the urine as it was collected. Each morning the fasting subjects were weighed on a beam-type balance to the nearest 10 grams. Every few days a sample of venous blood was withdrawn without stasis in an oiled syringe and determinations made of the serum concentrations of sodium and potassium, chloride," and total carbon dioxide content.t In some cases whole blood pH was measured with the glass electrode and in the others serum pH was measured colorimetrically."
The daily balance was calculated as net intake minus combined output in stool and urine. No liquid or unusually bulky stools were passed by any of the subjects in this study and daily fecal losses were assumed to be essentially constant within each collection period. The quantity of each substance determined in the pooled stool collections was therefore divided by the number of days in the collection period to obtain an average daily output. Changes in the volume of the "chloride space" and shifts of sodium and potassium into or out of intracellular water were calculated in the usual manner'o on the assumption that "chloride space" is essentially equivalent to the volume of extracellular fluid and that the latter constituted 20% of the body weight at the beginning of each study.
RESULTS
1. General effects. In all three of the subjects on high salt intake and in two of the three subjects on moderate salt intake, administration of DOCA produced an initial increase in weight which was most rapid in the high salt group. When treatment was continued for more than a week, the curve of weight gain tended to level off or to decline. A few subjects receiving salt developed mild peripheral edema. Two who were on high salt intakes showed occasional slight elevation of arterial diastolic pressure but there were no significant blood pressure changes in any of the others. Beginning several days after the initiation of treatment the majority of subjects complained of one or more symptoms including malaise, headache, anorexia, insomnia, and muscle cramps. In some cases these symptoms were severe enough to interfere with the optimal performance of daily tasks.
2. Effects on urine electrolytes, nitrogen, and acidity. The detailed balance data obtained from subject M. S., on a low salt intake, subject R. R., on a moderate salt intake, and subject B. Z., on a high salt intake, are presented in Tables 1, 2 , and 3 respectively. The results obtained in each of these experiments are typical of those obtained for each of the three dietary groups. In patient M. S., on low salt intake, (Table 1) , administration of DOCA for 11 days produced no significant change in the renal excretion of any of the measured electrolytes. In the other two patients (Tables 2 and 3) there was a prompt reduction in excretion of sodium and chloride with a concomitant urinary loss of potassium. In these cases and in all the other subjects on the moderate and high salt intakes, the reduction in sodium excretion exceeded the decrease in chloride. Sodium retention was initially much greater than the urinary potassium loss, and tended to diminish progressively. Usually within a week after treatment with DOCA had begun, urinary sodium and chloride excretion were equal to, or greater than, the control levels, although the potassium diuresis persisted. A more detailed description and analysis of the changes in sodium, chloride, and potassium balance will be presented in Section 5. It is worth noting here, however, that in none of the three subjects with moderate salt intakes and normal urine volumes did treatment with DOCA reduce urine sodium concentration to the levels often observed during physiological states demanding sodium retention. The minimum urine sodium concentration during the administration of DOCA was 24 to 50 mEq./L.
In subjects R. R. (Table 2 ), B. Z. (Table 3) , and in all the others receiving added salt, there was a small but definite rise in daily ammonia excretion which appeared within a few days after treatment had been started. The mean increment in ammonia excretion averaged 8 mEq./day for the subjects on moderate salt intake and 14 mEq./day for those on high salt intake. The maximum increment in ammonia excretion above the largest control value was 13-30 mEq./day for the subjects on high salt intake, and 11-18 mEq./day for the subjects on moderate intake. In the three patients on medium salt intake in whom post-treatment observations were made, ammonia excretion promptly returned to normal. A compensa. tory "rebound" occurred in only one patient (R. R.). These changes were apparently independent of urine pH, which did not change significantly. In one subject on low salt intake, R. R., there was a small transient increase of ammonia excretion at the inception of treatment, but there were no changes in the other two subjects, V. B. and M. S.
Urinary excretion of nitrogen, phosphorus, and titratable acidity was essentially unaffected by administration of DOCA in all subjects.
3. Stool composition. The average daily fecal excretion of sodium, potassium, and chloride for each group of three subjects before, during, and after treatment with DOCA is summarized in Table 4 . These data are difficult to interpret because of the limited number of collection periods and the small quantities of electrolyte involved. The data suggest, however, that treatment with DOCA reduced stool sodium content in the high salt group and increased stool potassium content in all subjects. No control periods, stool sodium content was lowest in the subjects on low-salt diets. 4. Serum electrolytes. Serum potassium concentration decreased in every subject given moderate or large amounts of salt but did not change 5. Sodium chloride and potassium balances. In Figures 1-9 are depicted the changes effected by DOCA in the net balances of sodium, chloride, and potassium (the latter was corrected for changes in nitrogen balance with an assumed K: N ratio of 2.7 mEq. K/gm. N). The data for these charts were obtained by algebraically subtracting the average control daily balance from the balance for each subsequent day. This can be assumed to correct for any systematic methodological error and for constant skin losses of electrolytes.
From Figures 1-3 it can clearly be seen that treatment of the three patients on a low-salt diet with 20 or 40 mgm. of DOCA per day for eight to eleven days produced a small retention of sodium and chloride and only a small variable loss of potassium. In subject V. B. (Fig. 1 ) the potassium diuresis tended to decrease with continued treatment. In subject R. R. (Fig. 2 doubled, small but probably significant potassium losses occurred. In neither of these latter two subjects was there any significant retention of potassium or loss of sodium in the post-treatment period. In sharp contrast with the above results were the large changes in electrolyte balance observed in the six subjects given salt. In Figures 4-9 it may be seen that in each case DOCA produced an immediate retention of sodium and chloride and a loss of potassium. The large initial retentions of sodium and chloride quickly diminished, however, and usually by the end of a week daily sodium and chloride balance had returned to control levels or were actually negative. The total amount of sodium and chloride retention defined by these charts appeared to be proportional to the sodium intake, since the largest positive balance changes were seen in the subjects given large amounts of salt (Figs. 7-9 ).
By contrast, the loss of potassium in excess of nitrogen continued unabated in mnost cases for as long as the hormone was given. In subjects E. A. (Fig. 4) and B. Z. (Fig. 7) , however, the potassium balance became reversed on the ninth and seventh days of treatment, respectively. In Table 6 are presented the cumulated and average daily potassium balances during administration of DOCA. These data are derived from Figures 4-9 , but the final days in Figures 4 and 7 , when potassium balances became positive again, have been omitted. The mean potassium losses averaged 27 mEq./day for the entire group. The daily losses appeared to be slightly greater in the subjects on high salt intake, but this difference is not of statistical significance. The mean total cumulated loss of potassium in excess of nitrogen was 168 mEq. Despite the magnitude of these changes, serum bicarbonate concentration changed in only one subject, and in this case only slightly.
In each of the three subjects on moderate salt intake in whom posttreatment periods were obtained (Figs. 4-6 ) cessation of treatment with DOCA resulted in a more or less prompt reversal of the initial changes in electrolyte balance.
6. Internal balances of sodium and potassium. In general, the changes in external sodium and chloride balance were parallel, but in all except one of SODIUM INTAKE /4 mEq. the subjects receiving added salt (E. A., Fig. 4 Table 7 . It should be noted that these calculations are based on the total cumulated balances for each period and do not refer to the changes in daily balance depicted in Figures 4-9 . The tabulated data show that in five of the six subjects given salt, treatment with DOCA caused a shift of sodium into cells of from 21 to 145 mEq., and a simultaneous loss of cellular potassium of from 88 to 205 mEq. There was no apparent quantitative DAYS FIG. 4 correlation between the cellular exchanges of sodium and potassium during the treatment period. In the subjects on moderate salt intake followed through a post-treatment period, these changes became approximately reversed. DISCUSSION The data presented here afford ample confirmation of the fact that DOCA produces in normal subjects given sodium chloride an initial retention of sodium and chloride and an increased excretion of potassium without change in nitrogen or phosphorus balance. It seems equally clear, however, that with the doses employed here the initial effect on sodium and chloride is only transient and usually disappears within a week despite (Fig. 1) and R. R. (Fig. 2 ment of relative refractoriness to the effects of DOCA by renal tubular cells is a possibility which cannot be evaluated at present, but it must be considered unlikely in view of the fact that DOCA can maintain sodium balance in patients with adrenocortical insufficiency for indefinite periods. It seems more probable that sodium balance was restored by other regulatory mechanisms. These might involve rapid expansion of plasma volume and increase in glomerular filtration rate, changes which usually occur following treatment of normal subjects5"' or dogs' with salt-retaining adrenal steroids and which are often associated under other circumstances with increased salt excretion."' The dependence of potassium diuresis upon the level of sodium chloride intake was one of the striking findings in this study. In one subject on a low-salt diet (M. S., Table 1 and Fig. 3 ) there was absolutely no loss of potassium. This phenomenon has been independently observed by Seldin, Welt, and Cort.' In the other two subjects on low-salt diets the losses of potassium were much smaller and less sustained than those observed in all of the six other subjects given added salt. Thus it would appear that the potassium diuresis produced by DOCA is dependent in some way upon sodium chloride intake. Similar conclusions may be drawn from observations on the effects of Compound F.'
The continuation of potassium loss for several days after sodium retention had stopped indicates that there is no direct relationship between net retention of sodium and loss of potassium. It is possible, however, that increased potassium excretion depends upon an augmented rate of renal tubular reabsorption of sodium, which continues while DOCA is administered, even after increases in glomerular filtration rate have restored sodium excretion to normal. The smaller, more variable increases in potassium excretion observed in two of the subjects on the low-salt diet may have resulted from the smaller increments in sodium reabsorption permitted under these circumstances. The eventual dissipation of potassium diuresis may be the result of hypokalemia and a diminishing load of potassium delivered to the renal tubules, or else the direct result of renal tubular potassium depletion.
It is of interest to note that relatively large losses of potassium in excess of nitrogen occurred in our subjects without the development of alkalosis. Others have reported that alkalosis may accompany potassium deficits of this magnitude produced by administration of ACTH or Cortisone.' This difference cannot be attributed to the relation of dietary chloride to sodium'm because this was the same in both groups. It would appear either that the difference is due to chance variation in the individual response of the subjects studied or that factors other than potassium depletion are involved in the production of alkalosis with ACTH and Cortisone.
The internal balances summarized in Table 6 show no quantitative relationship between exchanges of sodium and potassium. However, these data must be interpreted with the greatest caution because in only a few instances are the calculated shifts large enough to be of even statistical significance.' The direction of the shifts is nevertheless uniform enough to allow the conclusion that during treatment with DOCA cell balances of sodium probably did become positive while corrected potassium balances became negative. It is also worth noting that no significant cellular shifts occurred during the control period in the subjects given large quantities of extra salt as daily saline infusions. Other workers have noted that large loads of sodium chloride did not increase intracellular sodium content in normal adults17 or in normal dogs' but intracellular Na content was apparently increased by sodium chloride loading in a normal infant studied by Gamble et al. ' The changes produced in renal ammonia secretion are of considerable significance although they were small and variable. There was no relation between urine acidity and ammonia content. It is of interest, moreover, that ammonia excretion increased in all of the subjects given salt although it was affected, and then but slightly, in only one of the three subjects on a saltfree diet. Others have shown that adrenal insufficiency reduces renal synthesis of ammonia both in vivo"'5" and in vitro'5 and that administration of DOCA or added dietary salt will improve this function in adrenalectomized dogs.10 Interpretation of these observations must await further study of the factors controlling ammonia production.
SUMMARY AND CONCLUSIONS Electrolyte and nitrogen balance studies have been carried out on normal young adults who were given 20 to 40 mgm. of DOCA intramuscularly for periods of three to eleven days.
In six subjects whose diets were supplemented with moderate or large amounts of salt, administration of DOCA produced immediate retention of sodium and chloride, and a loss of potassium. The retention of sodium exceeded that of chloride and was greatest in subjects given the highest salt intake. With continued administration of the hormone, sodium retention diminished, and often a sodium diuresis appeared.
The negative balance of potassium averaged 27 mEq./day. This loss, unaccompanied by change in nitrogen balance, continued beyond the period of sodium retention, and regularly resulted in hypokalemia. The cumulative deficits of potassium ranged from 92 to 237 mEq., and were accompanied by intracellular shifts of sodium. There were no significant changes in serum bicarbonate or chloride concentration.
The three subjects on low sodium diets failed to show the changes in potassium balance described above. In one of these subjects there was no loss of potassium; in another, potassium diuresis did not appear until the seventh day of treatment; in the third subject, loss of potassium was minimal and only transient.
Ammonia excretion increased in all the subjects given salt but rose in only one subject on a low-salt diet. In the latter instance, the change was small and transitory. In no subjects were there significant changes in urine pH, titratable acidity, or in phosphorus excretion.
The observations in this study are consistent with the view that the increased potassium excretion as well as the small increases in ammonia secretion produced by treatment with DOCA are in some way conditioned by the simultaneous augmentation of renal tubular reabsorption of sodium and chloride. Eventual escape from the sodium-retaining effect of DOCA is probably the result of regulatory mechanisms which override the hormonal effect on the renal tubule.
